Charlotte's Web is the Budweiser of CBD!!
Hey Friends!
Charlotte’s Web (OTC: CWBHF) is one of the nation’s largest growers of hemp. And it’s laser-focused on the medical uses of cannabis. In fact, Charlotte’s Web was founded from Big Pharma’s failures.
Stanley Brothers is the founder of Charlotte’s Web. The company began researching medical cannabis when the Stanley brothers’ uncle developed pancreatic cancer in 2008. Conventional medicine just wasn’t helping.
Their research and company came to the forefront when the brothers met Paige Figi. Her daughter Charlotte had Dravet syndrome, a form of epilepsy. Charlotte suffered through up to 300 grand mal seizures a week. By the time she was 5, all the family’s pharmaceutical options had been exhausted. Then she tried a CBD product created by Stanley Brothers. It was created from a special strain of hemp. And it worked.
Charlotte’s Web, the CBD product, reduced Charlotte’s seizures to just three per month. It succeeded where Big Pharma had failed. And Stanley Brothers named the product after her.
This incredible story spread across the country as the media got a hold of it. Everyone from The Wall Street Journal, Time and The New York Times to NBC and CNN, just to name a few, brought Charlotte’s story to the world.
The CNN story from 2013 was especially widely viewed, and I recommend reading it if you haven’t yet. The story helped change America’s mind on the cannabis issue.
And through it all, Charlotte’s Web became a powerful brand name and didn’t have to spend a cent on advertising. With the sort of brand recognition it’s cultivating, we could be looking at the Budweiser of cannabis.
And in case you’re wondering, Charlotte’s case wasn’t a fluke. Scientists have given Charlotte’s Web a close look. And even in situations where Charlotte’s Web wasn’t a complete fix for epilepsy, it did improve quality of life for patients treated with it.
Charlotte’s Web succeeding where Big Pharma failed and they single handedly changed perspectives on medical marijuana…
It convinced then-Florida Gov. Rick Scott, a rather conservative politician, to sign his state’s proposed medical marijuana law back in 2014.
Charlotte’s Web might be small, but it has staying power. The numbers bear that out.
The company has seen rapid growth in revenue. It generated $69.5 million last year. Revenue is projected to grow to $126 million by the end of 2019 and reach $303.5 million in 2020.
It’s seen a 73.7% year-over-year revenue growth rate.
Charlotte’s Web also has a huge cash reserve relative to its liabilities – $51.4 million to $8.7 million.
Between its explosive growth potential and healthy balance sheet, the company’s current sub-$10 share price is a ridiculous steal.
I fully expect this company to maintain its spot as the No. 1 brand in CBD and grow into a multibillion-dollar firm over coming years. You don’t have to feel guilty about making money from Charlotte’s Web’s growth. All the money is clean.
Cannabis has dozens of medical uses. That means there are dozens of opportunities for companies like Charlotte’s Web to explore.
Investing in Charlotte’s Web is a fantastic way to break Murder Inc.’s hold on American medicine while positioning yourself to reap a windfall. The company was recently granted the first patent on a hemp plant in the U.S., which I believe will help cement its brand and lock in future profits.
Stay ahead of the masses,
Seth Maniscalco
Charlotte’s Web (OTC: CWBHF) is one of the nation’s largest growers of hemp. And it’s laser-focused on the medical uses of cannabis. In fact, Charlotte’s Web was founded from Big Pharma’s failures.
Stanley Brothers is the founder of Charlotte’s Web. The company began researching medical cannabis when the Stanley brothers’ uncle developed pancreatic cancer in 2008. Conventional medicine just wasn’t helping.
Their research and company came to the forefront when the brothers met Paige Figi. Her daughter Charlotte had Dravet syndrome, a form of epilepsy. Charlotte suffered through up to 300 grand mal seizures a week. By the time she was 5, all the family’s pharmaceutical options had been exhausted. Then she tried a CBD product created by Stanley Brothers. It was created from a special strain of hemp. And it worked.
Charlotte’s Web, the CBD product, reduced Charlotte’s seizures to just three per month. It succeeded where Big Pharma had failed. And Stanley Brothers named the product after her.
This incredible story spread across the country as the media got a hold of it. Everyone from The Wall Street Journal, Time and The New York Times to NBC and CNN, just to name a few, brought Charlotte’s story to the world.
The CNN story from 2013 was especially widely viewed, and I recommend reading it if you haven’t yet. The story helped change America’s mind on the cannabis issue.
And through it all, Charlotte’s Web became a powerful brand name and didn’t have to spend a cent on advertising. With the sort of brand recognition it’s cultivating, we could be looking at the Budweiser of cannabis.
And in case you’re wondering, Charlotte’s case wasn’t a fluke. Scientists have given Charlotte’s Web a close look. And even in situations where Charlotte’s Web wasn’t a complete fix for epilepsy, it did improve quality of life for patients treated with it.
Charlotte’s Web succeeding where Big Pharma failed and they single handedly changed perspectives on medical marijuana…
It convinced then-Florida Gov. Rick Scott, a rather conservative politician, to sign his state’s proposed medical marijuana law back in 2014.
Charlotte’s Web might be small, but it has staying power. The numbers bear that out.
The company has seen rapid growth in revenue. It generated $69.5 million last year. Revenue is projected to grow to $126 million by the end of 2019 and reach $303.5 million in 2020.
It’s seen a 73.7% year-over-year revenue growth rate.
Charlotte’s Web also has a huge cash reserve relative to its liabilities – $51.4 million to $8.7 million.
Between its explosive growth potential and healthy balance sheet, the company’s current sub-$10 share price is a ridiculous steal.
I fully expect this company to maintain its spot as the No. 1 brand in CBD and grow into a multibillion-dollar firm over coming years. You don’t have to feel guilty about making money from Charlotte’s Web’s growth. All the money is clean.
Cannabis has dozens of medical uses. That means there are dozens of opportunities for companies like Charlotte’s Web to explore.
Investing in Charlotte’s Web is a fantastic way to break Murder Inc.’s hold on American medicine while positioning yourself to reap a windfall. The company was recently granted the first patent on a hemp plant in the U.S., which I believe will help cement its brand and lock in future profits.
Stay ahead of the masses,
Seth Maniscalco
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.